Skorda, Aikaterini <br/><br/>
Non-lethal proteasome inhibition activates pro-tumorigenic pathways in multiple myeloma cells.  [electronic resource] 

 -  Journal of cellular and molecular medicine  12 2019 
 - 8010-8018 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1582-4934 
<br/><br/><label>Standard No.: </label>10.1111/jcmm.14653  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Bone Marrow--drug effects<br/>Bortezomib--pharmacology<br/>Carcinogenesis--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Chemokine CXCL10--metabolism<br/>Humans<br/>Interleukin-6--metabolism<br/>Interleukin-8--metabolism<br/>Multiple Myeloma--drug therapy<br/>Oligopeptides--pharmacology<br/>Proteasome Endopeptidase Complex--genetics<br/>Proteasome Inhibitors--pharmacology<br/>Proteomics<br/>Recurrence<br/>STAT3 Transcription Factor--antagonists & inhibitors<br/>STAT6 Transcription Factor--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>Tumor Microenvironment--drug effects